Abrysvo, the newly available bivalent vaccine for mothers from Pfizer has been shown to reduce the risk of hospitalization by 57 percent for infants with RSV.
An infant RSV vaccine is also available. However, it is unlikely that both the maternal and infant RSV vaccines are necessary, according to the CDC. Unless, “a baby is born less than two weeks after maternal immunization, then a doctor may recommend that the baby also receive the infant immunization,” the agency stated in a news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
